2-aminoimidazoles in medicinal chemistry

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 13, 2013, Pages 1921-1943

  Žula, Aleš ^a   Kikelj, Danijel ^a   Ilaš, Janez ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

2 aminoimidazole; Alkaloids; Lead compounds; Marine compounds; Medicinal chemistry; Scaffold; Secondary metabolites

Indexed keywords

2 AMINOIMIDAZOLE; ACYLGUANIDINE; AGELIFERIN; AXINELLAMINE; BENZAMIDINE; BROMOAGELIFERIN; CEFOTAXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLATHRIDIMINE; CYLINDRADINE; DIBROMOAGELIFERIN; GUANIDINE; IMIDAZOLE DERIVATIVE; ISONAAMIDINE; ISONAAMINE; KEALIININE; KERAMIDINE; MAURITAMINE; MECILLINAM; NAAMIDINE; NAAMINE; NAGELAMIDE; NAKAMURIC ACID; OROIDIN; PYRRONAMIDINE; SCEPTRIN; TYROKERADINE B; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADRENERGIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTICHOLINERGIC EFFECT; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; BIOASSAY; BIOFILM; CARDIOVASCULAR SYSTEM; HUMAN; IC 50; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; HUMANS; IMIDAZOLES;

EID: 84888043230     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557511313130007     Document Type: Review

References (143)

1. Al-Mourabit, A.; Zancanella, M., A.; Tilvi, S.; Romo, D. Biosynthesis, asymmetric synthesis, and pharmacology, including cellular targets, of the pyrrole-2-aminoimidazole marine alkaloids. Nat. Prod. Rep., 2011, 28, 1229-1260.
2. a) A. D Dayan. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica, 2003, 86, 141-159. b) Abelson, M.B.; Kaplan, A.P. A randomized, double-blind, placebo-controlled comparison of emedastine 0. 05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model. Clinical Therapeutics, 2002, 24, 445-456.
3. a) Sullivan, J.D.; Giles, R.L.; Looper, R.E. 2-Aminoimidazoles from Leucetta Sponges: Synthesis and Biology of an Important Pharmacophore. Curr. Bioact. Compd., 2009, 40, 39-78. b) Koswatta P.B., Lovely C.J. Structure and synthesis of 2-aminoimidazole alkaloids from Leucetta and Clathrina sponges. Nat. Prod. Rep., 2011, 28, 511-528.
4. Cafieri, F.; Fattorusso, E.; Taglialatela-Scafati, O. Novel bromopyrrole alkaloids from the sponge Agelas dispar. J. Nat. Prod., 1998, 61, 122-125.
5. Endo, T.; Tsuda, M.; Okada, T.; Kobayashi, J. Nagelamides A-H, new dimeric Bromopyrrole alkaloids from marine sponge Agelas species. J. Nat. Prod., 2004, 67, 1262-1267.
6. Eder, C.; Proksch, P.; Wray, V. New bromopyrrole alkaloids from indopacific sponge Agelas nakamurai. J. Nat. Prod., 1999, 62, 1295-1297.
7. Berman, V.S.; Roll, D.M.; Ireland, C.M.; Greenstein, M.; Maiese, W.M.; Steinberg, D.A. A study on the mechanism of action of sceptrin, an antimicrobial agent isolated from the South Pacific sponge Agelas mauritiana. J. Antimicrob Chemother, 1993, 32, 539.
8. Foss, M.H.; Eun, Y., Weibel, D.B. Chemical-biological studies of subcellular organization in bacteria. Biochemistry, 2011, 50, 7719-7734.
9. Richards, J.J.; Ballard, T.E.; Melander, C. Synthesis and screening of an oroidin library against Pseudomonas aeruginosa biofilms. ChemBioChem, 2008, 9, 1267-1279.
10. Sachiko, T.; Haruko, K.; Nobuhiro, F. Mauritiamine, a new antifouling oroidin dimer from the marine sponge Agelas mauritiana. J. Nat. Prod., 1996, 59, 501.
11. Urban, S.; Carroll, A.R.; Fechner, A.G.; Smith, J.; Hooper, J.N.A.; Quinn, R.J. Axinellamines A-D, movel imidazo-azolo-imidazole alkaloids from the Australian marine sponge Axinella sp. J. Org. Chem., 1999, 64, 731-735.
12. Forte, B.; Malgesini, B.; Piutti, C.; Quartieri, F.; Scolaro, A.; Paneo, G. A submarine Journey: The pyrrole-imidazole alkaloids. Mar. Drugs, 2009, 7, 705-753.
13. Roue, M.; Domart-Coulon, I.; Ereskovsky, A.; Perez, T.; Bourguet-Kondracki, M.L. Cellular localization of clathridimine, an antimicrobial 2-aminoimidazole alkaloid produced by the mediterranean calcareous sponge Clathrina clathrus. J. Nat. Prod., 2010, 73, 1277-1282.
14. Mukai, H.; Kubota, T.; Aoyama, K.; Mikami, Y.; Kobayashi, J. Tyrokeradines A and B, new bromotyrosine alkaloids with an imidazolyl-quinolinone moiety from a Verongid sponge. Bioorg. Med. Chem. Lett., 2009, 19, 1337-1339.
15. a of the C-7 heterocycle. J. Med. Chem., 1991, 34, 1110-1116.
16. a of the C-7 aminoimidazole on antibacterial spectrum and β-lactamase stability. J. Antibiotics, 1993, 46, 992-1012.
17. Musk, D.J.; Hergenrother, P.J. Chemical countermeasures for the control of bacterial biofilms: effective compounds and promising targets. Curr. Med. Chem., 2006, 13, 2163-2177.
18. Davies, D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov., 2003, 2, 114-122.
19. Geske, G.D.; Wezeman, R.J.; Siegel, A.P.; Blackwell, H.E. Small molecule inhibitors of bacterial quorum sensing and biofilm formation. J. Am. Chem. Soc., 2005, 127, 12762-12763.
20. Hentzer, M.; Riedel, K.; Rasmussen, T.B.; Heydorn, A.; Parsek, M.R.; Rice, S.A.; Molin, S.; Kjelleberg, S.; Givskov, M. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology, 2002, 148, 87-102.
21. Hu, J.F.; Garo, E.; Goering, M.G.; Yoo, H.D.; Esser, T.; Sestrich, J.; Hough, G.W.; Perrone, P.; Lee, Y.S.L.; Costerton, J.W.; Eldrich, G.R. Bacterial biofilm inhibitors from Diospyros dendo. J. Nat. Prod., 2006, 69, 118-120.
22. Yamada, A.; Kitamura, H.; Yamaguchi, K.; Fukuzawa, S.; Yazawa, K.; Kuramoto, M.; Wang, G.Y.S.; Fujitani, Y.; Uemura, D.B. Development of chemical substances regulating biofilm formation. Bull. Chem. Soc. Jpn., 1997, 70, 3061-3069.
23. Richards, J.J.; Ballard, E.T.; Melander, C. Inhibition and dispersion of Pseudomonas aeruginosa biofilms with reverse amide 2-aminoimidazole oroidin analogues. Org. Biomol. Chem., 2008, 6, 1356-1363.
24. Liu, C.; Worthington J.R.; Melander, C., Wu, H. A new smallmolecule specifically inhibits the cariogenic Streptococcus mutans in multispecies biofilms. Antimicrob. Agents Chemother., 2011, 55, 2679-2687.
25. Driscoll, J.A.; Brody, S.L.; Kollef, M.H. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs, 2007, 63, 351-368.
26. Costerton, J.W. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol., 2001, 9, 50-52.
27. Richards, J.J.; Ballard, E.T.; Melander, C. Inhibition and dispersion of Pseudomonas aeruginosa biofilms with reverse amide 2-aminoimidazole oroidin analogues. Org. Biomol. Chem., 2008, 6, 1356-1363.
28. Ballard, E.T.; Richards, J.J.; Aquino, A.; Reed, C.S.; Melander, C. Antibiofilm activity of a diverse oroidin library generated through reductive acylation. J. Org. Chem., 2009, 74, 1755-1758.
29. Richard, J.J.; Reyes, S.; Stowe, D.S.; Tucker, A.T.; Ballard, E.T.; Cavanagh, J.; Melander, C. Amide isosteres of oroidin: assessment of antibiofilm activity and C. elegans toxicity. J. Med. Chem., 2009, 52, 4582-4585.
30. Rogers, S.A.; Melander, C. Construction and screening of a 2-aminoimidazole library identifies a small molecule capable of inhibiting and dispersing bacterial biofilms across order, class and phylum. Angew. Chem. Int. Ed., 2008, 47, 5229-5231.
31. Bunders, A.C.; Richards, J.J.; Melander, C. Identification of aryl 2-aminoimidazoles as biofilm inhibitors in Gram-negative bacteria. Bioor. Med. Chem. Lett., 2010, 20, 3797-3800.
32. Falagas, E.M.; Koletsi, P.K.; Bliziotis, I.A. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol., 2006, 55, 1619-1629.
33. Reyes, S.; Huigens III, W.R.; Su, Z.; Simon, M.L.; Melander, C. Synthesis and biological activity of 2-aminoimidazole triazoles accessed by Suzuki-Miyaura cross-coupling. Org. Biomol. Chem., 2011, 9, 3041-3049.
34. Su, Z.; Rogers, S.A.; McCall, W.S.; Smith, A.C.; Mullikin, T.; Melander, C. A nitroenolate approach to the synthesis of 4, 5-disubstituted-2-aminoimidazoles. Pilot library assembly and screening for antibiotic and antibiofilm activity. Org. Biomol. Chem., 2010, 8, 2814-2822.
35. Harris, T.L.; Worthington, R.J.; Melander, C. A facile synthesis of 1, 5-disubstituted-2-aminoimidazoles: antibiotic activity of a first generation library. Bioorg. Med. Chem. Lett., 2011, 21, 4516-4519.
36. Peng, L.; DeSousa, J.; Su, Z.; Novak, B.M.; Nevzorov, A.A.; Garland, E.R., Melander, C. Inhibition of Acinetobacter baumannii biofilm formation on a methacrylate polymer containing a 2-aminoimidazole subunit. Chem. Commun., 2011, 47, 4896-4898.
37. Garau, J.; Bouza, E.; Chastre, J.; Gudiol, F.; Harbarth, S. Management of methicillin-resistant Staphylococcus aureus infections. Clin. Microbiol. Infect., 2009, 15, 125-136.
38. Rogers, S.A.; Bero, J.D.; Melander, C. Chemical synthesis and biological screening of 2-aminoimidazole-based bacterial and fungal antibiofilm agents. ChemBioChem, 2010, 11, 396-410.
39. Rogers, S.A.; Lindsey, E.A.; Whitehead, D.C.; Mullikin, T.; Melander, C. Synthesis and biological evaluation of 2-aminoimidazole/ carbamate hybrid anti-biofilm and anti-microbial agents. Bioorg. Med. Chem. Lett., 2011, 21, 1257-1260.
40. Huigens III, W.R.; Rogers, S.A.; Steinhauer, A.T.; Melander, C. Inhibition of Acinetobacter baumannii, Staphylococcus aureus and Pseudomonas aeruginosa biofilm formation with a class of TAGEtriazole conjugates. Org. Biomol. Chem., 2009, 7, 794-802.
41. Huigens III, W.R.; Reyes, S.; Reed, S.C.; Bunders, C.; Rogers, S.A.; Steinhauer, A.T.; Melander, C. The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii. Bioorg. Med. Chem., 2010, 18, 663-674.
42. Rogers, S.A.; Krayer, M.; Lindsey S.J.; Melander C. Tandem dispersion and killing of bacteria from a biofilm. Org. Biomol. Chem., 2009, 7, 603-606.
43. Nitzan, Y.; Balzam-Sudakevitz, A.; Ashkenazi, H. Eradication of Acinetobacter baumannii by photosensitized agents in vitro. J. Photoch. Photobio. B-Biology, 1998, 42, 211-218.
44. Rogers, S.A.; Huigens III, R.W.; Cavanagh, J.; Melander, C. Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob. Agents Chemother., 2010, 54, 2112-2118.
45. Fu, X.; Schmitz, F.J.; Tanner, R.S.; Kelly-Borges, M. New imidazole alkaloids and zinc complexes from the micronesian sponge Leucetta cf. chagosensis. J. Nat. Prod., 1998, 61, 384-386.
46. Hassan, W.; Edrada, R.; Ebel, R.; Wray, V.; van Soest, R.; Wiryowidagdo, S.; Proksch, P. New imidazole alkaloids from the indonesian sponge Leucetta chagosensis. J. Nat. Prod., 2004, 67, 817-822.
47. Dunbar, D.C.; Rimoldi, J.M.; Clark, A.M.; Hamann, M.T. Anticryptococcal anr nitric oxide synthase inhibitory imidazole alkaloids from the calcareous sponge Leucetta cf. chagosensis. Tetrahedron, 2000, 56, 8795-8798.
48. Araki, A.; Kubota, T.; Aoyama, K.; Mikami, Y.; Fromont, J.; Kobayashi, J. Nagelamides Q and R, novel dimeric bromopyrrole alkaloids from sponges Agelas sp. Org. Lett., 2009, 11, 1785-1788.
49. Mohammed, R.; Peng, J.; Kelly, M.; Hamann, M.T. Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. J. Nat. Prod., 2006, 69, 1739-1744.
50. Plobrukarn, A.; Smith, D.W.; Cramer, R.E.; Davidson, B.S. (2E, 9E)-pyronaamidine 9-(N-methylimine), a new imidazole alkaloid from the Northern Mariana Islands sponge Leucetta sp. cf. chagosensis. J. Nat. Prod., 1997, 60, 712-715.
51. Nishimura, S.; Matsunaga, S.; Suzuki, K.; Furihata, K.; van Soest, R.W.M.; Fusetani, N. Massadine, a novel geranylgeranyltransferase type I inhibitor from the marine sponge Stylissa aff. massa. Org. Lett., 2003, 5, 2255-2257.
52. Gross, H.; Kehraus, S.; König, M.G.; Woerheide, G.; Wright, A.D. New and biologically active imidazole alkaloids from two sponges of the genus Leucetta. J. Nat. Prod., 2002, 65, 1190-1193.
53. Tsukamoto, S.; Kawabata, T.; Kato, H.; Ohta, T.; Rotinsulu, H.; van Soest, R.W.M.; Ukai, K.; Kobayashi, H.; Namikoshi, M. Naamidines H and I, cytotoxic imidazole alkaloids from the indonesian marine sponge Leucetta chagosensis. J. Nat. Prod., 2007, 70, 1658-1660.
54. Akee, R.K.; Carroll, T.R.; Yoshida, W.Y.; Scheuer, P.J.; Stout, T.J.; Clardy, J. Two imidazole alkaloids from a sponge. J. Org. Chem., 1990, 55, 1944-1946.
55. Kinnel, R.B.; Gehrken, H.P.; Swali, R.; Skoropowski, G.; Scheuer, P.J. Palau'amine and its congeners a family of bioactive bisguanidines from the marine sponge Stylotella aurantium. J. Org. Chem., 1998, 63, 3281-3286.
56. Kinnel, R.B.; Gehrken, H.P.; Scheuer, P.J. Palau'amine: A cytotoxic and immunosuppresive hexacyclic bisguanidine antibiotic from the sponge Stylotella agminata. J. Am. Chem. Soc., 1993, 115, 3376-3377.
57. Tabudravu, J.N.; Jaspars, M. Purealidin S and purpuramine J, bromotyrosine alkaloids from the Fijian marine sponge Druinella sp. J. Nat. Prod., 2002, 65, 1798-1801.
58. Kuramoto, M.; Miyake, N.; Ishimaru, Y.; Ono, N.; Uno, H. Cylindradines A and B: novel bromopyrrole alkaloids from the marine sponge Axinella cylindratus. Org. Lett., 2008, 10, 5465-5468.
59. Morales, J.J.; Rodriguez, A.D. The structure of clathrodin, a novel alkaloid isolated from the caribbean sea sponge Agelas clathrodes. J. Nat. Prod., 1991, 54, 629-631.
60. Lavelle, F.; Zerial, A.; Fizames, C.; Rabault, B.; Curaudeau, A. Antitumor activity and mechanism of action of the marine compound girodazole. Invest. New Drugs, 1991, 9, 233-244.
61. Catimel, G.; Coquard, R.; Guastalla, J.P.; Merrouche, Y.; Alakl, M.K.; Dumortier, A.; Foy, M.; Clavel, M. Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors. Cancer Chemother. Pharmacol., 1995, 35, 246-248.
62. Copp, B.R.; Fairchild, C.R.; Cornell, L.; Casazza, M.A.; Robinson, S.; Ireland, C.M. Naamidine A is an antagonist of the epidermal growth factor receptor and an in vivo active antitumor agent. J. Med. Chem., 1998, 41, 3909-3911.
63. Kobayashi, J.; Inaba, K.; Tsuda, M. Tauroacidins A and B, new bromopyrrole alkaloids possessing a taurine residue from Hymeniacidon sponge. Tetrahedron, 1997, 53, 16679-16682.
64. Kobayashi, J.; Honna, K.; Sasaki, T.; Tsuda, M. Purealidins J-R, new bromotyrosine alkaloids from the Okinawan marine sponge Psammaplysilla purea. Chem Pharm Bull, 1995, 43, 403-407.
65. Aberle, N.S.; Lessene, G.; Watson, K.G. A Concise Total Synthesis of Naamidine A. Org. Lett., 2006, 8, 419-421.
66. Kobayashi, J.; Inaba, K.; Tsuda, M. Konbu'acidin A, a new bromopyrrole alkaloid with cdk4 inhibitory activity from Hymeniacidon sponge. Tetrahedron, 1997, 53, 15681-15684.
67. Yang, C.-G; Wang, J.; Jiang, B. Enantioselective synthesis of the aminoimidazole segment of dragmacidin D. Tetrahedron Letters, 2002, 43, 1063-1066.
68. da Silva, F.R.; Tessis, C.A.; Ferreira, P.F.; Rangel, L.P.; Garcia-Gomes, A.S.; Pereira, F.R.; Berlinck, R.G. S; Muricy, G.; Ferreira-Pereira, A. Oroidin inhibits the activity of the multudrug resistance target Pdr5p from yeast plasma membranes. J. Nat. Prod., 2011, 74, 279-282.
69. Gottesman, M.M.; Fojo, T.; Bates, E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer, 2002, 2, 48-58.
70. Krishna, R.; Mayer, L.D. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci., 2000, 11, 265-283.
71. Miyazawa, K.; Shinozaki, M.; Hara, T.; Furuya, T.; Miyazono, K. Two major Smad pathways in TGF-beta superfamily signaling. Genes Cells, 2002, 7, 1191-1204.
72. Lahn, M.; Klocker, S.; Berry, B.S. TGF-beta inhibitors, for the treatment of cancer. Expert. Opin Invest. Drugs., 2005, 14, 629-643.
73. Bonafoux, D.; Chuaqui, C.; Boriack.-Sjodin, A.; Fitch, C.; Hankins, G.; Josiah, S.; Black, C.; Hetu, G.; Ling, L.; Lee, W-C. 2-Aminoimidazoles inhibitors of TGF-β receptor 1. Bioorg. Med. Chem. Lett., 2009, 19, 912-916.
74. Reigan, P.; Edwards, N.P.; Gbaj, A.; Cole, C.; Barry, S.T.; Ashton, S.E.; Luke, R.W.A.; Douglas, K.T.; Stratford, I.J.; Bryce, R.A.; Freeman, S. Aminoimidazolylmethyluracil analogues as potent inhibitors of thymidine phosphorylase and their bioreductive nitroimidazolyl prodrugs. J. Med. Chem., 2005, 48, 392-402.
75. Liekens, S.; Bronckaers, A.; Perez-Perez, M.-J.; Balzarini, J. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy. Biochem. Pharmacol., 2007, 74, 1555-1567.
76. Anderson, R.F.; Patel, K.B.; Reghebi, K.; Hill, S.A. Conversion of xanthine dehydrogenase to xanthine oxidase as a positive marker for hypoxia in tumors and normal tissues. Br. J. Cancer, 1989, 60, 193-197.
77. Jain, H.V.; Rasheed, R.; Kalman, T.I. The role of phosphate in the action of thymidine phosphorylase inhibitors: Implications for the catalytic mechanism. Bioorg. Med. Chem. Lett., 2010, 20, 1648-1651.
78. Hynes, R.O. Integrins: bi-derectional, allosteric, signaling machines. Cell, 2002, 110, 673-687.
79. Cox, D.; Aoki, T.; Sekie, J.; Motoyama, Y.; Yoshida, K. The pharmacology of the integrins. Med. Res. Rev., 1994, 14, 195-228.
80. 3 antagonist promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 1994, 79, 1157-1164.
81. 3. J. Med. Chem., 2000, 43, 27-40.
82. Shen, X.; Perry, T.L.; Dunbar, C.D.; Kelly-Borges, M.; Hamann, T. Debromosceptrin, an alkaloid from the Caribbean sponge Agelas conifer. J. Nat. Prod., 1998, 61, 1302-1303.
83. Nicholas, G.M.; Eckman, L.L.; Ray, S.; Hughes, R.O.; Pfefferkorn, J.A.; Nicolaou, K.C.; Bewley, A.C. Bromotyrosine-derived natural and synthetic products as inhibitors of mycothiol-s-conjugate amidase. Bioorg. Med. Chem. Lett., 2002, 12, 2487-2490.
84. Tasdemir, D.; Topaloglu, B.; Perozzo, R.; Brun, R.; Carballeira N.M.; Zhang, X.; Tonge, P.J.; Linden, A.; Ruedi, P. Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tubercolosis and Echerichia coli. Bioorg. Med. Chem., 2007, 15, 6834-6845.
85. Scala, F.; Fattorusso, E.; Menna, M.; Taglialatela-Scafati, O.; Tierney, M.; Kaiser, M.; Tasdemir, D. Bromopyrrole alkaloids as lead compounds against protozoan parasites. Mar. Drugs, 2010, 8, 2162-2174.
86. Benoit-Vical, F.; Salery, M.; Soh, P., N.; Ahond, A.; Poupat, C. Girolline: a potential lead structure for antiplasmodial drug research. Planta Med., 2008, 74, 438-444.
87. O'Malley, D.; Li, K.; Maue, M.; Zografos, A.L.; Baran, P.S. Total synthesis of dimeric pyrrole-imidazole alkaloids: sceptrin, ageliferin, nagelamide E, oxysceptrin, nakamuric acid, axinellamine carbon skeleton. J. Am. Chem. Soc., 2007, 129, 4762-4775.
88. Parkers, K.E.B.; Bushnell, D.J.; Dunsdon, S.J.; Freeman, A.C.; Gunn, M.P.; Hopkings, R.A.; Lambert, R.W.; Merrett, J.H.; Spurden, W.C.; Thomas, G.J. Studies towards the large-scale synthesis of the HIV proteinase inhibitor ro 31-8959. J. Org. Chem., 1994, 59, 3656-3664.
89. Wilkerson, W.W.; Hollis, A.Y.; Cheatham, W.W.; Lam, G.N.; Erickson, V.S.; Cordova, B.C.; Klabe, R.M.; Meek, J.I. A bis-[N-3-(1-hydroxy-1-methyl-ethyl)-benzyl]-cyclic urea as a HIV protease inhibitor. Bioor. Med. Chem. Lett., 1995, 5, 3027-3032.
90. Wilkerson, W.W.; Dax, S.; Cheatham, W.W. Nonsymmetrically substituted cyclic urea HIV protease inhibitors. J. Med. Chem., 1997, 40, 4079-4088.
91. 7 receptor, an important inflammatory target. J. Org. Med., 2007, 72, 2309-2317.
92. Baraldi, P.G.; De Carmen Nunez, M.; Morelli, A.; Falzoni, S.; Di Virgilio, F.; Romagnoli, R. Synthesis and biological activity of Narylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor. J. Med. Chem., 2003, 46, 1318-1329.
93. Alcaraz, L.; Baxter, A.; Bent, J.; Braddock, M.; Cladingboel, D.; Donald, D.; Fagura, M.; Furber, M.; Laurent, C.; Lawson, M.; McCormick, M.; Roberts, N.; Robertson, M. Novel P2X7 receptor antagonists. Bioorg. Med. Chem. Lett., 2003, 13, 4043-4046.
94. Chan, G.W.; Mong, S.; Hemling, M.E.; Freyer, A.J.; DeBrosse, C.W.; Sarau, H.M.; Westley, J.W. New leukotriene B4 receptor antagonist: leucettamine A and related imidazole alkaloids from the marine sponge Leucetta microraphis. J. Nat. Prod., 1993, 56, 116-121.
95. Knorr, B.; Franchi, L.M.; Bisgaard, H.; Vermeulen, J.H.; LeSouef, P.; Santanello, N.; Michele, T.M.; Reiss, T.F.; Nguyen, H.H.; Bratton, D.L. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics, 2001, 108, 48.
96. 4 receptor antagonist leucettamine A and related analogues. J. Med. Chem., 1993, 36, 3333-3340.
97. 2B adrenoreceptor agonist isolated from the Australian marine sponge, Acanthella costata. Bioorg. Med. Chem., 2009, 17, 2497-2500.
98. Kobayashi, J.; Nakamura, H.; Ohizumi, Y.; α-Adrenoreceptor blocking action of hymenin, a novel marine alkaloid. Experientia, 1988, 44, 86-87.
99. Sanders, R.D.; Maze, M.; Alpha2-adrenoceptor agonists. Curr. Opin. Investig. Drugs, 2007, 8, 25-33.
100. Maze, M.; Tranquilli, W. Alpha-2 adrenoreceptor agonist: defining the role in clinical anesthesia. Anesthesiology, 1991, 74, 581-605.
101. th American Chemical Society National Meeting. New Orleans, LA, March 1996.
102. 2-adrenergic agonist. J. Med. Chem., 1997, 40, 18-23.
103. Cafieri, F.; Carnuccio, R.; Fatturusso, E.; Taglialatela-Scafati, O.; Vallefuoco, T. Anti. histaminic activity of bromopyrrole alkaloids isolated from Caribbean Agelas sponges. Bioorg. Med. Chem. Lett., 1997, 7, 2283-2288.
104. Fattorusso, E.; Taglialatela-Scafati, O. Two novel pyrroleimidazole alkaloids from the Mediterranean sponge Agelas oroides. Tetrahedron Letters, 2000, 41, 9917-9922.
105. Ciminiello, P.; Dell'Aversano, C.; Fattorusso, E.; Magno, S. Chemistry of verongida sponges, XI. Archerine, a novel antihistaminic bromotyrosine-derived compound from the Carribean marine sponge Aplysina archeri. Eur. J. Org. Chem., 2001, 1, 55-60.
106. 2-receptor antagonists. J. Med. Chem., 1985, 28, 1628-1636.
107. 2-receptor antagonist. J. Med. Chem., 1986, 29, 2154-2163.
108. Bickmeyer, U.; Grube, A.; Klings, K.-W.; Köck, M. Disturbance of voltage-induced cellular calcium entry by marine dimeric and tetrameric pyrrole-imidazole alkaloids. Toxicon, 2007, 50, 490-497.
109. Bickmeyer, U.; Drechsler, C.; Köck, M.; Assmann, M. Brominated pyrrole alkaloids from marine Agelas sponge reduce depolarization-induced cellular calcium elevation. Toxicon, 2004, 44, 45-51.
110. Rentas, A.L.; Rosa, R.; Rodriguez, A.D.; De Motta, G.E. Effect of alkaloid toxins from tropical marine sponges on membrane sodium currents. Toxicon, 1995, 33, 491-497.
111. Jenkinson, C.P.; Grody, W.W.; Cederbaum, S.D. Comparative properties of arginases. Comp. Biochem. Physiol., 1996, 114B, 107-132.
112. Li, H.; Romieu, I.; Sienra-Monge, J.-J.; Kistner, E.O.; Gjessing, H.K.; Lara-Sanchez, I.C.; Chiu, G.Y.; London, S.J. Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J. Allergy Clin. Immunol., 2006, 117, 119-126.
113. Ilies, M.; Di Costanzo, L.; North, M.L.; Scott, J.A.; Christianson, D.W. 2-Aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I. J. Med. Chem., 2010, 53, 4266-4276.
114. Knowles, R.G.; Moncada, S.; Nitric oxide synthases in mammals. Biochem. J., 1994, 298, 249-258.
115. Muscará, M.N.; Wallace, J.L. Therapeutic, potential of nitric oxide donors and inhibitors. Am. J. Physiol.-Gastrointest. Liver, 1999, 276, 1313-1316.
116. + exchange structure, regulation, and its role in heart disease. Circ. Res., 1999, 85, 777-786.
117. + exchanger. Ann. Rev. Physiol., 1985, 47, 545-560.
118. Baumgarth, M.; Beier, N.; Gericke, R. (2-Methyl-5-(methylsulfonyl) benzoyl)guanidine Na+/H+ antiporter inhibitors. J. Med. Chem., 1997, 40, 2017-2034.
119. Touret, N.; Tanneur, V.; Godart, H.; Seidler, R.; Taki, N.; Bürger, E.; Dämmgen, J., Counillon, L. Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and cardioprotective effects. Eur. J. Pharmacol., 2003, 459, 151-158.
120. Guzman-Perez, A.; Wester, R.T.; Allen, M.C.; Brown, J.A.; Buchholz, A.R.; Cook, E.R.; Day, W.W.; Kennedy, S.P.; Knight, D.R.; Marala, R.B.; Mularski, C.J.; Novomisle, W.A.; Tracey, W.R.; Hill, R.J. Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility. Bioorg. Med. Chem. Lett., 2001, 11, 803-807.
121. + exchange system and its dependence on internal pH. EMBO J., 1984, 3, 1865-1870.
122. Ahmad, S.; Ngu, K.; Combs, D.W.; Wu, S.C.; Weinstein, D.S.; Liu, W.; Chen, B.C.; Chandrasena, G.; Dorso, C.R.; Kirby, M.; Atwal, K. Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1. Bioorg. Med. Chem. Lett., 2004, 14, 177-180.
123. Atwal, K.S.; O'Neil, S.V.; Ahmad, S.; Doweyko, L.; Kirby, M.; Dorso, C.R.; Chandrasena, G.; Chen, B.C.; Zhao, R.; Zahler, R. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1Himidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors. Bioorg. Med. Chem. Lett., 2006, 16, 4796-4799.
124. Kato, T.; Shizuri, Y.; Izumida, H.; Yokoyama, A.; Endo, M. Styloguanidines, new chitinase inhibitors from the marine sponge Stylotella Aurantium. Tetrahedron Lett., 1995, 36, 2133-2136.
125. 5 compounds isolated from Agelas sponges. Experientia, 1992, 48, 885-887.
126. Hesketh, P.J.; Gandara, D.R. Serotonin Antagonists: A New Class of Antiemetic Agents. J. Natl. Cancer Inst., 1991, 83, 613-620.
127. Tatsumi, M.; Groshan, K.; Blakely, R.D.; Richelson, E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur. J. Pharm., 1997, 340, 249-58.
128. Kobayashi, J.; Ohizumi, Y.; Nakamura, H.; Hirata, Y. A novel antagonist of serotonergic receptors, hymenidin, isolated from the Okinawanmarine sponge Hymeniacidon sp. Experientia, 1986, 42, 1176-1177.
129. Nakamura, H.; Ohizumi, Y.; Kobayashi, J. Keramidine, a novel antagonist of serotonergic receptors isolated from the Okinawan sea sponge Agelas sp. Tetrahedron Lett., 1984, 25, 2475-2478.
130. Nakamura, Y.; Kobayashi, M.; Nakamura, H.; Wu, H.; Kobayashi, J.; Ohizumi, Y. Purealin, a novel activator of skeletal muscle actomyosin ATPase and myosin EDTA-ATPase that enhanced the superprecipitation of actomyosin. Eur. J. Biochem., 1987, 167, 1-6.
131. Adelstein, R.S.; Conti, M, A. Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity. Nature, 1975, 256, 597-598.
132. Kobayashi, J.; Tsuda, M. Ageliferins, potent actomyosin ATPase activators from the Okinawan marine sponge Agelas sp. Tetrahedron, 1990, 46, 5579-5586.
133. Kobayashi, J.; Tsuda, M.; Ohizumi, Y. A potent actomyosin ATPase activator from the Okinawan marine sponge Agelas cf. nemoechinata. Experientia, 1991, 47, 301-304.
134. Lowe, G.; Sproat, S.B. Evidence for an associative mechanism in the phosphoryl transfer step catalyzed by rabbit muscle creatine kinase. The Journal of Biological Chemistry, 1980, 255, 3944-3951.
135. Gummert, J.F.; Ikonen, T.; Morris, R.E. Newer Immunosuppressive Drugs. J. Am. Soc. Nephrol., 1999, 10, 1366-1380.
136. Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature, 1999, 399, A23-A31.
137. Extance, A. Alzheimer's failure raises questions about diseasemodifying strategies. Nat. Rev. Drug Discov., 2010, 9, 749-751.
138. Hong, L.; Turner, R.T.; Koelsch, G.; Shin, D.; Ghosh, A.K.; Tang. J. Crystal Structure of Memapsin 2 (β-Secretase) in Complex with an Inhibitor OM00-3. Biochemistry, 2002, 41, 10963-10967.
139. Chiriano, G.; De Simone, A.; Mancini, F.; Perez, D.I.; Cavalli, A.; Bolognesi, M.L., Legname, G.; Martinez, A.; Andrisano, V.; Carloni, P.; Roberti, M. A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: Structure-based design, synthesis, and biological evaluation. Eur. J. Med. Chem., 2012, 48, 206-213.
140. Bouchet, M.-J.; Rendon, A.; Wermuth, C.G., Goeldner, M.; Hirth, C. Aryl diazo compounds and diazonium salts as potential irreversible probes of the γ-aminobutyric acid receptor. J. Med. Chem., 1987, 30, 2222-2227.
141. Vassas, A.; Bourdy, G.; Paillard, J.J.; Lavayre, J.; Païs, M.; Quirion, J.C.; Debitus, C. Naturally occurring somatostatin and vasoactive intestinal peptide inhibitors. Isolation of alkaloids from two marine sponges. Planta Medica, 1996, 62, 28-30.
142. Bissette, G.; Cook, L.; Smith, W.; Dole, C.K.; Crain, B.; Nemeroff, C.B. Regional Neuropeptide Pathology in Alzheimer's Disease: Corticotropin-Releasing Factor and Somatostatin. Journal of Alzheimer's Disease, 1998, 1, 91-105.
143. Lee, H.C.; Kumar, P.; McEwan, A.J.; Wiebe, L.I.; Mercer, J.R. Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside. Nuclear Medicine and Biology, 2000, 27, 61-68.